B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Cash from Financing Activities Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Cash from Financing Activities
kr137.2m
CAGR 3-Years
67%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Cash from Financing Activities
kr38.1m
CAGR 3-Years
-38%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
L
Lytix Biopharma AS
OSE:LYTIX
Cash from Financing Activities
-kr943k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash from Financing Activities
-kr3.9m
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Cash from Financing Activities
$43.7m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash from Financing Activities
kr168k
CAGR 3-Years
-93%
CAGR 5-Years
-76%
CAGR 10-Years
-40%

See Also

What is Bergenbio ASA's Cash from Financing Activities?
Cash from Financing Activities
137.2m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Cash from Financing Activities amounts to 137.2m NOK.

What is Bergenbio ASA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
13%

Over the last year, the Cash from Financing Activities growth was -37%. The average annual Cash from Financing Activities growth rates for Bergenbio ASA have been 67% over the past three years , 13% over the past five years .

Back to Top